Capricor Therapeutics Stock Statistics
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
| Dates | Signal | Change |
|---|---|---|
| 2023-03-28 - 2023-03-28 | HOLD | 0 |
| 2023-03-24 - 2023-03-28 | SELL | -0.485 |
| 2023-03-23 - 2023-03-24 | HOLD | -1.67 |
| 2023-03-21 - 2023-03-23 | SELL | -4.77 |
| 2023-03-20 - 2023-03-21 | BUY | -1.79 |
Stock Score Effectiveness
Bollinger Stock Signal Effectiveness
Macd Signal Effectiveness
Mv7 Signal Effectiveness
Score signal
Bollinger Signal Statistics
MV signal statistics
MACD Signal Statistics
About Capricor Therapeutics
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
